Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some ...

French biotech MaaT Pharma has signed a licensing and distribution agreement with UK-based Clinigen, positioning the company ...

EU pharmaceutical regulation reforms needed to drive innovation and investment, ... which restrict revenues and margins for pharmaceutical companies. The EU's smaller market size compared to the US.

Join our API course for an in-depth understanding of active pharmaceutical ingredients in drug manufacturing. Learn the regulatory frameworks of the EU and USA, GMP and GDP practices, and key ...

Experts at HLTH Europe discussed how to ensure patients have trust in the EHDS to ensure a successful roll-out.

The EC’s upcoming review of pharmaceutical regulation, part of the EU Pharmaceuticals Strategy, comes as the region faces substantial unmet need in disease areas from cancers to Alzheimer’s, ...

But it is the pharmaceutical industry itself that’s stoking these fears. Big Pharma corporations never miss a chance to turn crisis into opportunity and to boost their already inflated profits. And ...

The EU's Commissioner for Trade Maroš Šefčovič is flying to Washington today for talks with senior Trump administration ...

Nearly three dozen global pharmaceutical companies, in a letter to the head of the European Commission, demanded help to maintain operations in the EU despite threatened U.S. tariffs on imports ...

Altogether, the “pharma package,” issued in the form of a directive and a regulation, represents “the biggest reform to EU’s laws on medicines in over two decades,” according to the Council.

President Trump’s administration once promised 90 deals in 90 days. When it comes to the European Union, it may be more of a ...